CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Aims to Support Mental Health, Develop Improved Treatments Using Psilocybin Mushrooms
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human-optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, offers a timely line of organic, non-GMO and vegan-certified products. In 2019, Johns Hopkins launched a center for psychedelic research backed by private funders (http://cnw.fm/1lTHD). A recent article discussing the company reads, “The focus of John Hopkin’s studies will be on the affect psychedelics have on behavior, brain function, learning and memory, and the brain’s biology and mood. New therapies and the effectiveness of psilocybin are…

















